2 search results
Lonza Invests in Product Development and Manufacturing
Lonza - a Swiss multinational chemicals and biotechnology company - has been investing in product development and manufacturing
Pharmaceutical manufacturing to reach US$673.6bn by 2027
ResearchAndMarkets.com's latest report reveals that the global pharmaceutical manufacturing industry is expected to reach US$673.6bn by 2027...